Search

everythinglearnresearchcommunity

for

Search:↓

An over-the-counter vitamin/mineral supplement improved hair loss and blood sugar control in a woman with non-classic 11-hydroxylase deficiency.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Myoinositol effectively manages PCOS with fewer side effects than metformin.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Methotrexate is not proven effective for inducing remission in ulcerative colitis.

Radiotherapy affects mitochondrial-related genes in metastatic breast cancer cells.

Methimazole for hyperthyroidism has known and new side effects needing more study for safety.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Finasteride and dutasteride may cause metabolic issues like liver disease and diabetes.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

Increasing Teneligliptin on his own caused a man's hair loss, which stopped when he ceased the medication.

SPIOMET therapy may be a promising alternative to oral contraceptives for treating adolescent PCOS.

The inhibitor affects androgen metabolism but not ovarian function.

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

The combination of encorafenib and binimetinib caused few skin issues.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Pranlukast and mirabegron may work as new diabetes drugs.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

Antiandrogens are somewhat effective in reducing excessive hair growth in women.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

New strategies like vitamin A and dextromethorphan can help reduce methotrexate side effects and improve patient adherence.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

MK-5108 is safe and shows potential against tumors, especially alone.